Hepatitis C in Developing Countries

Current and Future Challenges

Nonfiction, Science & Nature, Science, Biological Sciences, Microbiology, Health & Well Being, Medical
Cover of the book Hepatitis C in Developing Countries by , Elsevier Science
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9780128032343
Publisher: Elsevier Science Publication: November 23, 2017
Imprint: Academic Press Language: English
Author:
ISBN: 9780128032343
Publisher: Elsevier Science
Publication: November 23, 2017
Imprint: Academic Press
Language: English

Hepatitis C in Developing Countries: Current and Future Challenges explores the current state of HCV in several countries, including Africa, Asia and South America. It maintains a dedicated focus on the epidemiology, clinical patterns, virologic diversity, coinfections, natural history and progression, complications, and response to standard of care (SOC) pegylated interferon and ribavirin therapy of HCV with recommendations specific to middle and low income countries. Readers will find detailed information on the burden of HCV infection from a global health and economic perspective, along with data from multicenter trials on DAAs that have enrolled patients infected with HCV non-genotype 1.

  • Features coverage on the prevention of, or inhibition of, liver fibrosis, cirrhosis, and hepatocellular carcinoma
  • Presents data from trials on patients with diverse ethnic backgrounds and those infected with genotypes 3, 4, 5, 6
  • Addresses the epidemiology, modes of transmission, socio-political aspects, genotypes, and co-infections of Hepatitis C
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Hepatitis C in Developing Countries: Current and Future Challenges explores the current state of HCV in several countries, including Africa, Asia and South America. It maintains a dedicated focus on the epidemiology, clinical patterns, virologic diversity, coinfections, natural history and progression, complications, and response to standard of care (SOC) pegylated interferon and ribavirin therapy of HCV with recommendations specific to middle and low income countries. Readers will find detailed information on the burden of HCV infection from a global health and economic perspective, along with data from multicenter trials on DAAs that have enrolled patients infected with HCV non-genotype 1.

More books from Elsevier Science

Cover of the book Human Toxicology by
Cover of the book Streamline Numerical Well Test Interpretation by
Cover of the book The Performance of Photovoltaic (PV) Systems by
Cover of the book Economic Evaluation of Pharmacy Services by
Cover of the book Ferroelectricity in Doped Hafnium Oxide by
Cover of the book Handbook of Psychological Assessment by
Cover of the book Stress: Neuroendocrinology and Neurobiology by
Cover of the book Managing Foreign Research and Development in the People's Republic of China by
Cover of the book Guide to Research Techniques in Neuroscience by
Cover of the book Fundamental Biomaterials: Metals by
Cover of the book Ultrarelativistic Heavy-Ion Collisions by
Cover of the book Stochastic Dynamics. Modeling Solute Transport in Porous Media by
Cover of the book Advances in Parasitology by
Cover of the book Advances in Applied Microbiology by
Cover of the book Advanced Oxidation Processes for Wastewater Treatment by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy